# GCSH

## Overview
The GCSH gene encodes the glycine cleavage system protein H (H-protein), a pivotal component of the glycine cleavage system (GCS) located in the mitochondria. This protein plays a critical role in glycine metabolism and protein lipoylation, functioning as a hydrogen carrier within the GCS. The H-protein is characterized by a lipoylation site essential for its interaction with other components of the GCS, such as the P-protein, facilitating the oxidative cleavage of glycine. This process is vital for maintaining amino acid balance and energy production in cells. The H-protein's dual role in glycine metabolism and lipoate synthesis underscores its importance in cellular bioenergetics and one-carbon metabolism. Mutations in the GCSH gene can lead to metabolic disorders, including nonketotic hyperglycinemia, highlighting the clinical significance of this gene and its encoded protein (Leung2021Glycine; ArribasCarreira2022Pathogenic; Kure2001Chromosomal).

## Structure
The GCSH gene encodes the H-protein, a component of the glycine cleavage system, which is crucial for glycine metabolism and protein lipoylation. The H-protein contains a lipoylation site at the lysine residue 107, which is essential for its function in the glycine cleavage system and its interaction with the P-protein (ArribasCarreira2022Pathogenic; Kure2001Chromosomal). The structure of the H-protein includes a loop containing the lipoylation site, positioned above a tunnel that accesses the P-protein's active site (ArribasCarreira2022Pathogenic).

The secondary structure of the H-protein features a core β-sheet, which is crucial for its stability. Mutations such as Thr148Pro can destabilize this β-sheet due to proline's restricted flexibility, impacting the protein's function (ArribasCarreira2022Pathogenic). The tertiary structure is characterized by regions that include both hydrophobic and hydrophilic interactions, as seen with the His57Arg mutation, which disrupts a hydrophobic area and affects protein interactions (ArribasCarreira2022Pathogenic).

The H-protein undergoes post-translational modifications, including lipoylation, which is critical for its role in mitochondrial bioenergetics and enzyme function (ArribasCarreira2022Pathogenic). These structural features and modifications are vital for the protein's dual functions in glycine metabolism and lipoate synthesis.

## Function
The GCSH gene encodes the H-protein, a crucial component of the glycine cleavage system (GCS) located in the mitochondria of eukaryotic cells. This system is responsible for the oxidative cleavage of glycine, a process that releases carbon dioxide and ammonia while transferring a methylene group to tetrahydrofolate, which is essential for the mitochondrial folate cycle (Leung2021Glycine). The H-protein functions as a hydrogen carrier, transferring the aminomethyl moiety generated by glycine decarboxylation to the T-protein for further degradation, thus maintaining normal glycine levels in the body (Kure2001Chromosomal).

The H-protein also plays a significant role in protein lipoylation, a process vital for the activity of bioenergetic enzymes such as pyruvate dehydrogenase and 2-ketoglutarate dehydrogenase. This dual role is essential for cellular bioenergetics and one-carbon metabolism, intersecting two critical metabolic pathways necessary for cell survival (ArribasCarreira2022Pathogenic). The proper functioning of the GCS, facilitated by the H-protein, is crucial for maintaining amino acid balance and energy production in cells, and deficiencies in this system can lead to metabolic disorders such as nonketotic hyperglycinemia (ArribasCarreira2022Pathogenic).

## Clinical Significance
Mutations in the GCSH gene, which encodes the H-protein, are associated with combined nonketotic hyperglycinemia (NKH) and lipoate deficiency. These conditions result from disruptions in glycine metabolism and protein lipoylation, leading to significant metabolic dysfunctions. NKH is characterized by elevated glycine levels in plasma and cerebrospinal fluid, causing neurological symptoms such as seizures, severe hypotonia, and developmental delays, often resulting in early death (ArribasCarreira2022Pathogenic; Majethia2021Biallelic).

Specific pathogenic variants, such as His57Arg and Thr148Pro, have been shown to destabilize the H-protein, impairing its interaction with the P-protein and affecting mitochondrial bioenergetic capacity. These mutations lead to reduced pyruvate dehydrogenase (PDH) enzyme activity and decreased mitochondrial function (ArribasCarreira2022Pathogenic). The clinical phenotype often resembles NKH with additional symptoms similar to PDH deficiency, including movement disorders and lactic acidosis (ArribasCarreira2022Pathogenic).

The incidence of GCSH variants as a cause of NKH is rare, accounting for less than 1% among over 600 NKH subjects studied. The clinical presentations can range from severe neonatal forms to more attenuated phenotypes with longer-term survival (ArribasCarreira2022Pathogenic).

## Interactions
The GCSH gene encodes the H-protein, a crucial component of the glycine cleavage system (GCS), which interacts with several other proteins to facilitate glycine degradation. The H-protein forms part of a multi-enzyme complex that includes the P-protein (glycine decarboxylase, GLDC), T-protein (aminomethyltransferase, AMT), and L-protein (dehydrolipamide dehydrogenase, DLD) (Leung2021Glycine). The H-protein interacts specifically with the P-protein, where its lipoylated lysine accesses the P-protein's active site through a tunnel, indicating a direct interaction essential for its function (ArribasCarreira2022Pathogenic). This interaction is crucial for the transfer of the methylamine group from glycine, which is then used as a substrate by AMT (Leung2021Glycine).

Pathogenic variants in the GCSH gene can disrupt these interactions. For instance, the p.His57Arg variant is predicted to interfere with the interaction between the H-protein and P-protein by disrupting a hydrophobic region and losing a hydrogen bond with Tyr164, which is crucial for maintaining the interaction (ArribasCarreira2022Pathogenic). These disruptions can lead to impaired glycine metabolism and associated metabolic disorders (ArribasCarreira2022Pathogenic).


## References


[1. (Leung2021Glycine) Kit-Yi Leung, Sandra C. P. De Castro, Gabriel L. Galea, Andrew J. Copp, and Nicholas D. E. Greene. Glycine cleavage system h protein is essential for embryonic viability, implying additional function beyond the glycine cleavage system. Frontiers in Genetics, January 2021. URL: http://dx.doi.org/10.3389/fgene.2021.625120, doi:10.3389/fgene.2021.625120. This article has 13 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fgene.2021.625120)

[2. (ArribasCarreira2022Pathogenic) Laura Arribas-Carreira, Cristina Dallabona, Michael A Swanson, Joseph Farris, Elsebet Østergaard, Konstantinos Tsiakas, Maja Hempel, Cecile Aquaviva-Bourdain, Stefanos Koutsoukos, Nicholas V Stence, Martina Magistrati, Elaine B Spector, Kathryn Kronquist, Mette Christensen, Helena G Karstensen, René G Feichtinger, Melanie T Achleitner, J Lawrence Merritt II, Belén Pérez, Magdalena Ugarte, Stephanie Grünewald, Anthony R Riela, Natalia Julve, Jean-Baptiste Arnoux, Kasturi Haldar, Claudia Donnini, René Santer, Allan M Lund, Johannes A Mayr, Pilar Rodriguez-Pombo, and Johan L K Van Hove. Pathogenic variants ingcshencoding the moonlighting h-protein cause combined nonketotic hyperglycinemia and lipoate deficiency. Human Molecular Genetics, 32(6):917–933, October 2022. URL: http://dx.doi.org/10.1093/hmg/ddac246, doi:10.1093/hmg/ddac246. This article has 8 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1093/hmg/ddac246)

[3. (Majethia2021Biallelic) Purvi Majethia, Puneeth Hirivate Somashekar, Malavika Hebbar, Rajagopal Kadavigere, Balike Krishna Praveen, Katta Mohan Girisha, and Anju Shukla. Biallelic start loss variant, c.<scp>1a</scp> &gt; g in <scp>gcsh</scp> is associated with variant nonketotic hyperglycinemia. Clinical Genetics, 100(2):201–205, May 2021. URL: http://dx.doi.org/10.1111/cge.13970, doi:10.1111/cge.13970. This article has 4 citations and is from a peer-reviewed journal.](https://doi.org/10.1111/cge.13970)

[4. (Kure2001Chromosomal) S. Kure, K. Kojima, T. Kudo, K. Kanno, Y. Aoki, Y. Suzuki, T. Shinka, Y. Sakata, K. Narisawa, and Y. Matsubara. Chromosomal localization, structure, single-nucleotide polymorphisms, and expression of the human h-protein gene of the glycine cleavage system (gcsh), a candidate gene for nonketotic hyperglycinemia. Journal of Human Genetics, 46(7):378–384, June 2001. URL: http://dx.doi.org/10.1007/s100380170057, doi:10.1007/s100380170057. This article has 28 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s100380170057)